治疗2级高血压。
Treating stage 2 hypertension.
作者信息
Giles Thomas D, Materson Barry J
机构信息
University of Miami School of Medicine, Miami, FL 3310, USA.
出版信息
J Clin Hypertens (Greenwich). 2005 Aug;7(8):464-70. doi: 10.1111/j.1524-6175.2005.04535.x.
Abstract
The prevalence of hypertension increases with advancing age, due primarily to increases in systolic blood pressure. Systolic hypertension is the most common form of hypertension in individuals over 50 years of age and reflects pathologic decreases in arterial compliance. Systolic blood pressure elevation is a more important risk factor for cardiovascular disease than is diastolic blood pressure elevation. Stage 2 hypertension, defined as blood pressure > or =160/100 mm Hg, is often found in older persons, who are at highest risk for cardiovascular events. In this clinical review, hypertension experts utilize a case study to provide a paradigm for treating older patients with stage 2 hypertension.
摘要
高血压的患病率随年龄增长而增加，主要原因是收缩压升高。收缩期高血压是50岁以上人群中最常见的高血压形式，反映了动脉顺应性的病理性降低。收缩压升高比舒张压升高是心血管疾病更重要的危险因素。2级高血压定义为血压≥160/100 mmHg，常见于老年人，他们发生心血管事件的风险最高。在本临床综述中，高血压专家利用一个病例研究为治疗老年2级高血压患者提供一个范例。
相似文献
1
Treating stage 2 hypertension.
J Clin Hypertens (Greenwich). 2005 Aug;7(8):464-70. doi: 10.1111/j.1524-6175.2005.04535.x.
2
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Rev Port Cardiol. 1999 Oct;18(10):897-906.
3
Treating hypertension in the elderly: protagonist viewpoint.
Am J Geriatr Cardiol. 2003 Nov-Dec;12(6):361-2. doi: 10.1111/j.1076-7460.2003.02915.x.
4
[Isolated systolic hypertension as risk factor. Also in this case lowering blood pressure makes sense].
MMW Fortschr Med. 2000 Nov 23;142(47):26-8.
5
Isolated systolic hypertension: an important cardiovascular risk factor.
Blood Press. 1998 Jul;7(4):197-207. doi: 10.1080/080370598437222.
6
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
7
Systolic blood pressure: it's time to take control.
Am J Hypertens. 2004 Dec;17(12 Pt 2):49S-54S. doi: 10.1016/j.amjhyper.2004.08.020.
8
[Systolic hypertension-treat or not to treat?].
Herz. 2003 Dec;28(8):702-6. doi: 10.1007/s00059-003-2505-9.
9
Prevalence and implications of uncontrolled systolic hypertension.
Drugs Aging. 2003;20(4):277-86. doi: 10.2165/00002512-200320040-00004.
10
Hypertension in older people: part 2.
J Clin Hypertens (Greenwich). 2006 Jul;8(7):521-5. doi: 10.1111/j.1524-6175.2006.05116.x.
引用本文的文献
1
The Association between Magnesium Depletion Score and Hypertension in US Adults: Evidence from the National Health and Nutrition Examination Survey (2007-2018).
Biol Trace Elem Res. 2024 Oct;202(10):4418-4430. doi: 10.1007/s12011-023-04034-y. Epub 2023 Dec 26.
2
Advancement in the Cuffless and Noninvasive Measurement of Blood Pressure: A Review of the Literature and Open Challenges.
Bioengineering (Basel). 2022 Dec 24;10(1):27. doi: 10.3390/bioengineering10010027.
3
Blood Pressure Measurement: From Cuff-Based to Contactless Monitoring.
Healthcare (Basel). 2022 Oct 21;10(10):2113. doi: 10.3390/healthcare10102113.
4
Advances in Cardiovascular Biomarker Discovery.
Biomedicines. 2020 Nov 30;8(12):552. doi: 10.3390/biomedicines8120552.
5
The influence of locus control on adherence to treatment regimen among hypertensive patients.
Patient Prefer Adherence. 2011 Apr 20;5:141-8. doi: 10.2147/PPA.S15098.
本文引用的文献
1
Diuretic-related side effects: development and treatment.
J Clin Hypertens (Greenwich). 2004 Sep;6(9):532-40. doi: 10.1111/j.1524-6175.2004.03789.x.
2
The burden of adult hypertension in the United States 1999 to 2000: a rising tide.
Hypertension. 2004 Oct;44(4):398-404. doi: 10.1161/01.HYP.0000142248.54761.56. Epub 2004 Aug 23.
3
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Am J Hypertens. 2004 Jun;17(6):495-501. doi: 10.1016/j.amjhyper.2004.02.003.
4
Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1043-8. doi: 10.1161/01.ATV.0000129331.21092.1d. Epub 2004 Apr 22.
5
Adverse prognostic significance of new diabetes in treated hypertensive subjects.
Hypertension. 2004 May;43(5):963-9. doi: 10.1161/01.HYP.0000125726.92964.ab. Epub 2004 Mar 22.
6
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Hypertension. 2003 Dec;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2. Epub 2003 Dec 1.
7
Patient knowledge and awareness of hypertension is suboptimal: results from a large health maintenance organization.
J Clin Hypertens (Greenwich). 2003 Jul-Aug;5(4):254-60. doi: 10.1111/j.1524-6175.2003.01963.x.
8
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.
JAMA. 2003 Jul 9;290(2):199-206. doi: 10.1001/jama.290.2.199.
9
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.
BMJ. 2003 Jun 28;326(7404):1427. doi: 10.1136/bmj.326.7404.1427.
10
Better blood pressure control: how to combine drugs.
J Hum Hypertens. 2003 Feb;17(2):81-6. doi: 10.1038/sj.jhh.1001511.
Zotero 插件